• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二肽烯酸酯的抗原生动物和半胱氨酸蛋白酶抑制活性。

Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.

机构信息

Departament de Química Inorgànica i Orgànica, Universitat Jaume I, Avda. Sos Baynat s/n 12080 Castelló, Spain.

Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg 5, 55099 Mainz, Germany.

出版信息

Bioorg Med Chem. 2018 Sep 1;26(16):4624-4634. doi: 10.1016/j.bmc.2018.07.015. Epub 2018 Jul 10.

DOI:10.1016/j.bmc.2018.07.015
PMID:30037754
Abstract

A family of dipeptidyl enoates has been prepared and tested against the parasitic cysteine proteases rhodesain, cruzain and falcipain-2 related to sleeping sickness, Chagas disease and malaria, respectively. They have also been tested against human cathepsins B and L1 for selectivity. Dipeptidyl enoates resulted to be irreversible inhibitors of these enzymes. Some of the members of the family are very potent inhibitors of parasitic cysteine proteases displaying k (Ms) values of seven orders of magnitude. In vivo antiprotozoal testing was also performed. Inhibitors exhibited IC values in the micromolar range against Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and even more promising lower values against Leishmania donovanii.

摘要

已经制备了一组二肽烯酸酯,并对与昏睡病、恰加斯病和疟疾分别相关的寄生虫半胱氨酸蛋白酶 rhodesain、cruzain 和 falcipain-2 进行了测试。它们还针对人组织蛋白酶 B 和 L1 进行了选择性测试。二肽烯酸酯对这些酶表现出不可逆抑制作用。该家族的一些成员是寄生虫半胱氨酸蛋白酶的非常有效的抑制剂,对寄生虫半胱氨酸蛋白酶的抑制常数 (K (Ms)) 值达到了七个数量级。还进行了体内抗原生动物测试。抑制剂对恶性疟原虫、布氏锥虫、克氏锥虫的 IC 值在微摩尔范围内,对利什曼原虫的抑制作用更有前景,IC 值更低。

相似文献

1
Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.二肽烯酸酯的抗原生动物和半胱氨酸蛋白酶抑制活性。
Bioorg Med Chem. 2018 Sep 1;26(16):4624-4634. doi: 10.1016/j.bmc.2018.07.015. Epub 2018 Jul 10.
2
Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action.二肽基烯酸酯作为强效的罗得西亚锥虫蛋白酶抑制剂,具有双重作用模式。
ChemMedChem. 2015 Sep;10(9):1484-7. doi: 10.1002/cmdc.201500204. Epub 2015 Jul 14.
3
Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.作为半胱氨酸蛋白酶抑制剂的金化合物:作为抗寄生虫药物的药学应用前景。
Biometals. 2017 Apr;30(2):313-320. doi: 10.1007/s10534-017-0007-0. Epub 2017 Mar 10.
4
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.新型2H-异喹啉-3-酮类作为抗疟原虫法尼蛋白酶-2抑制剂
Bioorg Med Chem. 2009 Sep 15;17(18):6505-11. doi: 10.1016/j.bmc.2009.08.013. Epub 2009 Aug 12.
5
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.含有呈受限构象的3-溴异恶唑啉弹头的新型类二肽罗得西亚蛋白酶抑制剂的研发。
Bioorg Med Chem. 2015 Nov 1;23(21):7053-60. doi: 10.1016/j.bmc.2015.09.029. Epub 2015 Sep 21.
6
Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain.二肽基-α,β-环氧酯作为半胱氨酸蛋白酶克氏锥虫蛋白酶和罗德西亚锥虫蛋白酶的强效不可逆抑制剂。
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6697-700. doi: 10.1016/j.bmcl.2007.10.056. Epub 2007 Oct 22.
7
Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.设计、合成及生物评价强效瑞香烷肽腈类抑制剂及基于活性的探针作为有前景的抗布氏锥虫药物。
Chemistry. 2012 May 21;18(21):6528-41. doi: 10.1002/chem.201103322. Epub 2012 Apr 4.
8
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).开发新型基于肽的迈克尔受体,靶向罗得西亚锥虫蛋白酶和恶性疟原虫蛋白酶-2用于治疗被忽视的热带病(NTDs)。
J Med Chem. 2017 Aug 24;60(16):6911-6923. doi: 10.1021/acs.jmedchem.7b00405. Epub 2017 Aug 11.
9
Allicin and derivates are cysteine protease inhibitors with antiparasitic activity.大蒜素及其衍生物是具有抗寄生虫活性的半胱氨酸蛋白酶抑制剂。
Bioorg Med Chem Lett. 2010 Sep 15;20(18):5541-3. doi: 10.1016/j.bmcl.2010.07.062. Epub 2010 Aug 6.
10
Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.评估二肽腈作为布氏锥虫主要半胱氨酸蛋白酶罗德西亚蛋白酶抑制剂的作用。
Bioorg Med Chem Lett. 2017 Jan 1;27(1):45-50. doi: 10.1016/j.bmcl.2016.11.036. Epub 2016 Nov 15.

引用本文的文献

1
Profiling Cysteine Proteases Activities in Neuroinflammatory Cells.分析神经炎症细胞中的半胱氨酸蛋白酶活性。
ChemMedChem. 2025 Feb 1;20(3):e202400520. doi: 10.1002/cmdc.202400520. Epub 2024 Nov 20.
2
Integrated Computational Approaches for Drug Design Targeting Cruzipain.靶向 cruzipain 的药物设计的综合计算方法。
Int J Mol Sci. 2024 Mar 27;25(7):3747. doi: 10.3390/ijms25073747.
3
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of .新型克氏锥虫半胱氨酸蛋白酶抑制剂的发现
Curr Med Chem. 2024;31(16):2285-2308. doi: 10.2174/0109298673254864230921090519.
4
Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L.二肽基酮迈克尔受体弹头对半胱氨酸蛋白酶组织蛋白酶L抑制机制的影响
ACS Catal. 2023 Oct 3;13(20):13354-13368. doi: 10.1021/acscatal.3c02748. eCollection 2023 Oct 20.
5
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?三十年靶向疟原虫裂殖体蛋白研发抗疟药物:我们从中得到了哪些启示,下一步该怎么做?
Curr Med Chem. 2024;31(16):2234-2263. doi: 10.2174/0929867331666230913165219.
6
Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.用于被忽视疾病的共价抑制剂:新型治疗选择的探索
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1028. doi: 10.3390/ph16071028.
7
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors.基于结构的肽基乙烯基甲基酮的先导优化作为 SARS-CoV-2 主蛋白酶抑制剂。
Eur J Med Chem. 2023 Feb 5;247:115021. doi: 10.1016/j.ejmech.2022.115021. Epub 2022 Dec 15.
8
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.用于治疗非洲人类锥虫病的减少肽键拟肽迈克尔受体的开发。
Molecules. 2022 Jun 11;27(12):3765. doi: 10.3390/molecules27123765.
9
Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage.具有广泛化学覆盖范围的克鲁兹蛋白酶抑制剂预测性全局模型。
ACS Omega. 2021 Mar 5;6(10):6722-6735. doi: 10.1021/acsomega.0c05645. eCollection 2021 Mar 16.
10
The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site.恶性疟原虫 falcipain-2 蛋白酶与(E)-查尔酮类抑制剂复合物突出了一个新的、小分子结合位点。
Malar J. 2019 Dec 2;18(1):388. doi: 10.1186/s12936-019-3043-0.